Sponsor:
National Cancer Institute (NCI)
Code:
NCT03429036
Conditions
Hearing Disorder
Oral Mucosal Disease
Pharyngeal Neoplasm
Head and Neck Neoplasms
Laryngeal Disease
Eligibility Criteria
Sex: All
Age: 3 - 70+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Hearing Disorder
Oral Mucosal Disease
Pharyngeal Neoplasm
Head and Neck Neoplasms
Laryngeal Disease
Study ID
NCT03429036
Start date
May 23, 2018
Status verified date
Aug 5, 2026
Completion date
Dec 2, 2029
Anticipated
Primary completion date
Jun 3, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 3 - 70+
Healthy Volunteers: Not accepted
Enrollment
1000 participants
Anticipated
Arms
1
Primary outcome measure
Central contacts
Locations
MedStar Georgetown University Hospital
Recruiting
Washington D.C., District of Columbia, United States, 20007
Contacts
Johns Hopkins Hospital Sibley Memorial Hospital
Recruiting
Washington D.C., District of Columbia, United States, 20016
Contacts
George Washington University Hospital
Recruiting
Washington D.C., District of Columbia, United States, 20037
Contacts
Johns Hopkins Hospital Broadway Baltimore
Recruiting
Baltimore, Maryland, United States, 21205
Contacts
Johns Hopkins Hospital Bayview
Recruiting
Baltimore, Maryland, United States, 21224
Contacts
Johns Hopkins Hospital Greenspring
Recruiting
Baltimore, Maryland, United States, 21287
Contacts
Johns Hopkins Suburban Hospital
Recruiting
Bethesda, Maryland, United States, 20814
Contacts
Johns Hopkins Otolaryngology Clinic
Recruiting
Bethesda, Maryland, United States, 20817
Contacts
National Institutes of Health Clinical Center
Recruiting
Bethesda, Maryland, United States, 20892
Contacts
Sponsor
National Cancer Institute (NCI)
Last update posted
Aug 28, 2026
Last verified
Aug 5, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2026-08-28.